Deep Learning, Artificial Intelligence and Machine Learning are all terms that are frequently used interchangeably. Deep Learning and Artificial Intelligence both refer to the use of computer algorithms to solve complex tasks that are traditionally performed by humans. In contrast, Machine Learning is a subset of AI and is the use of algorithms and technologies to make sense of data. Deep Learning uses neural networks to allow computers to “learn” from data without being explicitly programmed. It is a powerful tool for learning complex patterns in a vast amount of data. Deep Learning algorithms are divided into three categories: supervised learning, unsupervised learning, and reinforcement learning. Supervised learning requires labeled data, and uses algorithms to observe patterns in data input and output. Unsupervised learning works with unlabeled data, while reinforcement learning uses a reward system to strengthen or weaken the response of the neural network. Neural networks can thus learn a skill set or respond to different inputs in an autonomous manner. Artificial Intelligence is a set of technologies that allow machines to automatically analyze data, learn from experiences, draw insights, and make intelligent decisions to improve workflows. AI can be used to solve complex problems in a short time frame, while providing effective results. AI is comprised of multiple technologies, such as natural language processing, image and speech recognition, deep learning, and artificial neural networks. Finally, Machine Learning is a subset of AI which focuses on providing algorithms with the ability to learn from data given as input, in order to make predictions about future data without being explicitly programmed for them. Machine Learning algorithms use techniques such as supervised and unsupervised learning to identify patterns in data and build models that can then be used to make predictions about unseen data. Deep Learning, Artificial Intelligence, and Machine Learning are all powerful technologies that are currently being used in a variety of industries and fields. By understanding the differences between the three, we can better leverage their combined potential to develop innovative solutions to complex challenges in the modern world.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States